Evidence map›Paper›PMID 28955823›Full record

ArticleBiochemistry and biophysics reports2016

IL-25, IL-33 and TSLP receptor are not critical for development of experimental murine malaria.

Akiko Shibui, Ayako Takamori, Mohammed E M Tolba, Aya Nambu, Eri Shimura, Sachiko Yamaguchi, Chizu Sanjoba, Hajime Suto, Katsuko Sudo, Ko Okumura and 5 more

Open access · goldAbstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. The IL-33/ST2 Pathway in Cerebral Malaria.International journal of molecular sciences · 2022
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei.Mammalian genome : official journal of the International Mammalian Genome Society · 2018
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Akiko ShibuiDepartment of Medical Genomics, Graduate School of Frontier Sciences, The University of Tokyo, Chiba 277-8561, Japan.
Ayako TakamoriLaboratory of Systems Biology, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Mohammed E M TolbaDepartment of Medical Genomics, Graduate School of Frontier Sciences, The University of Tokyo, Chiba 277-8561, Japan.
Aya NambuLaboratory of Systems Biology, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Eri ShimuraLaboratory of Systems Biology, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Sachiko YamaguchiLaboratory of Systems Biology, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Chizu SanjobaDepartment of Molecular Immunology, School of Agricultural and Life Sciences, The University of Tokyo, Tokyo 113-8657, Japan.
Hajime SutoAtopy Research Center, Juntendo University, Tokyo 113-8412, Japan.
Katsuko SudoAnimal Research Center, Tokyo Medical University, Tokyo 160-8402, Japan.
Ko OkumuraAtopy Research Center, Juntendo University, Tokyo 113-8412, Japan.
Sumio SuganoDepartment of Medical Genomics, Graduate School of Frontier Sciences, The University of Tokyo, Chiba 277-8561, Japan.
Hideaki MoritaDepartment of Allergy and Immunology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.
Hirohisa SaitoDepartment of Allergy and Immunology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.
Kenji MatsumotoDepartment of Allergy and Immunology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.
Susumu NakaeLaboratory of Systems Biology, Center for Experimental Medicine and Systems Biology, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan.
Systems Biology Institute · JPNational Center For Child Health and Development · JPThe University of Tokyo · JPJuntendo University · JPJapan Science and Technology Agency · JPTokyo Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IL-25, IL-33 and TSLP, which are produced predominantly by epithelial cells, can induce production of Th2-type cytokines such as IL-4, IL-5 and/or IL-13 by various types of cells, suggesting their involvement in induction of Th2-type cytokine-associated immune responses. It is known that Th2-type cytokines contribute to host defense against malaria parasite infection in mice. However, the roles of IL-25, IL-33 and TSLP in malaria parasite infection remain unclear. Thus, to elucidate this, we infected wild-type, IL-25

Indexed as

IL-25, interleukin-25IL-33, interleukin-33Interleukin-25Interleukin-33MalariaMouseThymic stromal lymphoproteinTSLPR, thymic stromal lymphoprotein receptor

Identifiers

PMID28955823
PMCPMC5600432
OpenAlexW2210176411

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.